Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Integrated Care in ESKD: Perspective of a Large Dialysis Organization.

Becker BN, Nissenson AR.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):445-447. doi: 10.2215/CJN.08300718. Epub 2019 Jan 29. No abstract available.

PMID:
30696663
2.

Greater access to transplantation should be a priority: A view of the Dialysis PATIENTS Demonstration Act.

Becker BN, Nissenson AR.

Am J Transplant. 2019 Apr;19(4):995-997. doi: 10.1111/ajt.15128. Epub 2018 Oct 29.

PMID:
30247816
3.

PRACTITIONER APPLICATION.

Becker BN.

J Healthc Manag. 2016 Mar-Apr;61(2):103-4. No abstract available.

PMID:
27111929
4.

AVOIDING MISSTEPS IN THE POPULATION HEALTH JOURNEY.

Becker BN.

Physician Leadersh J. 2016 Jan-Feb;3(1):44-6. No abstract available.

PMID:
26882593
5.

Medication Safety + Mobile Health = Patient Engagement in CKD.

Becker BN.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1314-5. doi: 10.2215/CJN.06970615. Epub 2015 Jul 28. No abstract available.

6.

Evaluating the Emergency Department as a Site of Transplant Care.

Becker BN, Becker YT.

Transplantation. 2015 Aug;99(8):1549-50. doi: 10.1097/TP.0000000000000780. No abstract available.

PMID:
26018354
7.

Rehospitalization after living kidney donation.

Becker BN, Becker YT.

Clin J Am Soc Nephrol. 2014 Feb;9(2):227-8. doi: 10.2215/CJN.12701213. Epub 2014 Jan 23. No abstract available.

8.

Those who can do, teach.

Becker BN, Becker YT.

Am J Kidney Dis. 2013 Jul;62(1):1-2. doi: 10.1053/j.ajkd.2013.04.004. No abstract available.

PMID:
23773836
9.

Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins.

Das S, Becker BN, Hoffmann FM, Mertz JE.

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S28. doi: 10.1186/1755-1536-5-S1-S28. eCollection 2012.

10.

Creatinine-based estimations of kidney function are unreliable in obese kidney donors.

Aggarwal N, Porter AC, Tang IY, Becker BN, Akkina SK.

J Transplant. 2012;2012:872894. doi: 10.1155/2012/872894. Epub 2012 Jan 19.

11.

Chemokines and their receptors in human renal allotransplantation.

Lo DJ, Weaver TA, Kleiner DE, Mannon RB, Jacobson LM, Becker BN, Swanson SJ, Hale DA, Kirk AD.

Transplantation. 2011 Jan 15;91(1):70-7. doi: 10.1097/TP.0b013e3181fe12fc.

12.

MicroRNAs in kidney function and disease.

Akkina S, Becker BN.

Transl Res. 2011 Apr;157(4):236-40. doi: 10.1016/j.trsl.2011.01.011. Epub 2011 Feb 3. Review.

13.

Factors affecting employment at initiation of dialysis.

Muehrer RJ, Schatell D, Witten B, Gangnon R, Becker BN, Hofmann RM.

Clin J Am Soc Nephrol. 2011 Mar;6(3):489-96. doi: 10.2215/CJN.02550310. Epub 2011 Mar 10.

14.

Editorial perspective. Donor kidney function - are we focusing on the trees or the forest?

Becker BN.

Am J Nephrol. 2011;33(3):207-8. doi: 10.1159/000323255. Epub 2011 Feb 18. No abstract available.

15.

The quality pyramid: the 2010 National Kidney Foundation presidential address.

Becker BN.

Am J Kidney Dis. 2011 Feb;57(2):185-7. doi: 10.1053/j.ajkd.2010.12.003. No abstract available.

PMID:
21251537
16.

The rationale, implementation, and effect of the Medicare CKD education benefit.

Young HN, Chan MR, Yevzlin AS, Becker BN.

Am J Kidney Dis. 2011 Mar;57(3):381-6. doi: 10.1053/j.ajkd.2010.10.056. Epub 2011 Jan 15. Review.

PMID:
21239094
17.

Filling the gap in CKD: The health care workforce and faculty development.

Becker BN.

Am J Kidney Dis. 2011 Feb;57(2):198-201. doi: 10.1053/j.ajkd.2010.08.032. Epub 2010 Nov 17.

PMID:
21087815
18.

"Venopathy" at work: recasting neointimal hyperplasia in a new light.

Yevzlin AS, Chan MR, Becker YT, Roy-Chaudhury P, Lee T, Becker BN.

Transl Res. 2010 Oct;156(4):216-25. doi: 10.1016/j.trsl.2010.07.004. Epub 2010 Aug 13. Review.

19.

Retrograde occlusive arteriography of hemodialysis access: failure to detect inflow lesions?

Chan MR, Chhokar VS, Young HN, Becker BN, Yevzlin AS.

Semin Dial. 2011 Jul-Aug;24(4):452-5. doi: 10.1111/j.1525-139X.2010.00761.x. Epub 2010 Aug 13.

PMID:
20723156
20.

A conflict of responsibility: no patient left behind.

Becker BN.

Clin J Am Soc Nephrol. 2010 May;5(5):744-5. doi: 10.2215/CJN.02610310. Epub 2010 May 6.

21.

Risk factors and screening for chronic kidney disease.

Vassalotti JA, Fox CH, Becker BN.

Adv Chronic Kidney Dis. 2010 May;17(3):237-45. doi: 10.1053/j.ackd.2010.03.003.

PMID:
20439092
22.

Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation.

Axelrod DA, McCullough KP, Brewer ED, Becker BN, Segev DL, Rao PS.

Am J Transplant. 2010 Apr;10(4 Pt 2):987-1002. doi: 10.1111/j.1600-6143.2010.03022.x.

23.

Commentary: dinosaurs fated for extinction? Health care delivery at academic health centers.

Becker BN, Formisano RA, Getto CJ.

Acad Med. 2010 May;85(5):759-62. doi: 10.1097/ACM.0b013e3181d5d00e.

PMID:
20305531
24.

Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

Stevens LA, Li S, Wang C, Huang C, Becker BN, Bomback AS, Brown WW, Burrows NR, Jurkovitz CT, McFarlane SI, Norris KC, Shlipak M, Whaley-Connell AT, Chen SC, Bakris GL, McCullough PA.

Am J Kidney Dis. 2010 Mar;55(3 Suppl 2):S23-33. doi: 10.1053/j.ajkd.2009.09.035.

25.

A software upgrade: CKD testing in 2010.

Becker BN, Vassalotti JA.

Am J Kidney Dis. 2010 Jan;55(1):8-10. doi: 10.1053/j.ajkd.2009.11.005. No abstract available.

PMID:
20053344
26.

Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.

Das S, Becker BN, Hoffmann FM, Mertz JE.

BMC Cell Biol. 2009 Dec 21;10:94. doi: 10.1186/1471-2121-10-94.

27.

WITHDRAWN: Endothelium in the allograft.

Becker BN, Fain SB, Sadowski EA, Djamali A, Jaffery JB, Jacobson LM.

Kidney Int. 2009 Sep 9. [Epub ahead of print]

PMID:
19741588
28.

Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys.

Sadowski EA, Djamali A, Wentland AL, Muehrer R, Becker BN, Grist TM, Fain SB.

Magn Reson Imaging. 2010 Jan;28(1):56-64. doi: 10.1016/j.mri.2009.05.044. Epub 2009 Jul 3.

29.

Quantitative MR measures of intrarenal perfusion in the assessment of transplanted kidneys: initial experience.

Wentland AL, Sadowski EA, Djamali A, Grist TM, Becker BN, Fain SB.

Acad Radiol. 2009 Sep;16(9):1077-85. doi: 10.1016/j.acra.2009.03.020. Epub 2009 Jun 17.

30.

Focusing on health literacy might help us cross the quality chasm.

Becker BN.

Am J Kidney Dis. 2009 May;53(5):730-2. doi: 10.1053/j.ajkd.2009.01.256. No abstract available.

PMID:
19393471
31.

Repositioning clinical care in the academic medicine.

Becker BN, Formisano R.

Physician Exec. 2009 Jan-Feb;35(1):40-5. No abstract available.

PMID:
19226984
32.

KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.

Gordon CE, Balk EM, Becker BN, Crooks PA, Jaber BL, Johnson CA, Michael MA, Pereira BJ, Uhlig K, Levin A.

Am J Kidney Dis. 2008 Nov;52(5):811-25. doi: 10.1053/j.ajkd.2008.08.005.

PMID:
18971009
33.

The home is where the donor might be.

Becker BN.

Am J Kidney Dis. 2008 Apr;51(4):542-4. doi: 10.1053/j.ajkd.2008.01.005. Review. No abstract available.

PMID:
18371528
34.

Disease progression and outcomes in type 1 diabetic kidney transplant recipients based on posttransplantation CKD staging.

Smavatkul C, Pascual J, Desai AG, Samaniego M, Becker BN, Djamali A.

Am J Kidney Dis. 2007 Oct;50(4):631-40.

PMID:
17900463
35.

CKD stage-to-stage progression in native and transplant kidney disease.

Kukla A, Adulla M, Pascual J, Samaniego M, Nanovic L, Becker BN, Djamali A.

Nephrol Dial Transplant. 2008 Feb;23(2):693-700. Epub 2007 Sep 19.

PMID:
17881429
36.

Trends in kidney transplantation rates and disparities.

Stolzmann KL, Bautista LE, Gangnon RE, McElroy JA, Becker BN, Remington PL.

J Natl Med Assoc. 2007 Aug;99(8):923-32.

37.

Medical care of kidney transplant recipients after the first posttransplant year.

Djamali A, Samaniego M, Muth B, Muehrer R, Hofmann RM, Pirsch J, Howard A, Mourad G, Becker BN.

Clin J Am Soc Nephrol. 2006 Jul;1(4):623-40. Epub 2006 Mar 29. Review.

38.

Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation.

Pascual J, Mezrich JD, Djamali A, Leverson G, Chin LT, Torrealba J, Bloom D, Voss B, Becker BN, Knechtle SJ, Sollinger HW, Pirsch JD, Samaniego MD.

Transplantation. 2007 Jun 15;83(11):1429-34.

PMID:
17565315
39.

Vascular access outcomes and medication use: a USRDS study.

Yevzlin AS, Conley EL, Sanchez RJ, Young HN, Becker BN.

Semin Dial. 2006 Nov-Dec;19(6):535-9.

PMID:
17150056
40.

Drug insight: maintenance immunosuppression in kidney transplant recipients.

Samaniego M, Becker BN, Djamali A.

Nat Clin Pract Nephrol. 2006 Dec;2(12):688-99. Review.

PMID:
17124526
41.

BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction.

Djamali A, Sadowski EA, Muehrer RJ, Reese S, Smavatkul C, Vidyasagar A, Fain SB, Lipscomb RC, Hullett DH, Samaniego-Picota M, Grist TM, Becker BN.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F513-22. Epub 2006 Oct 24.

42.

Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation.

Barth RN, Janus CA, Lillesand CA, Radke NA, Pirsch JD, Becker BN, Fernandez LA, Thomas Chin L, Becker YT, Odorico JS, D'Alessandro AM, Sollinger HW, Knechtle SJ.

Transpl Int. 2006 Nov;19(11):885-92.

43.

Noninvasive assessment of early kidney allograft dysfunction by blood oxygen level-dependent magnetic resonance imaging.

Djamali A, Sadowski EA, Samaniego-Picota M, Fain SB, Muehrer RJ, Alford SK, Grist TM, Becker BN.

Transplantation. 2006 Sep 15;82(5):621-8.

PMID:
16969284
44.

In-center hemodialysis patients' use of the internet in the United States: a national survey.

Schatell D, Wise M, Klicko K, Becker BN.

Am J Kidney Dis. 2006 Aug;48(2):285-91.

PMID:
16860195
45.

Strategic planning for departmental divisions in an academic health care center.

Becker BN, Formisano RA.

Am J Med. 2006 Apr;119(4):357-65. No abstract available.

PMID:
16564788
46.

Preemptive transplantation for patients with diabetes-related kidney disease.

Becker BN, Rush SH, Dykstra DM, Becker YT, Port FK.

Arch Intern Med. 2006 Jan 9;166(1):44-8.

PMID:
16401809
47.

Prevention of chronic allograft nephropathy with vitamin D.

Hullett DA, Laeseke PF, Malin G, Nessel R, Sollinger HW, Becker BN.

Transpl Int. 2005 Oct;18(10):1175-86.

48.

Assessment of acute renal transplant rejection with blood oxygen level-dependent MR imaging: initial experience.

Sadowski EA, Fain SB, Alford SK, Korosec FR, Fine J, Muehrer R, Djamali A, Hofmann RM, Becker BN, Grist TM.

Radiology. 2005 Sep;236(3):911-9.

PMID:
16118170
49.

ATR blockade reduces IFN-gamma production in lymphocytes in vivo and in vitro.

Weidanz JA, Jacobson LM, Muehrer RJ, Djamali A, Hullett DA, Sprague J, Chiriva-Internati M, Wittman V, Thekkumkara TJ, Becker BN.

Kidney Int. 2005 Jun;67(6):2134-42.

50.

Life after transplantation: new transitions in quality of life and psychological distress.

Muehrer RJ, Becker BN.

Semin Dial. 2005 Mar-Apr;18(2):124-31. Review.

PMID:
15771656

Supplemental Content

Loading ...
Support Center